ShareProphets : tidm

BME

B&M European Value Retail is quite punchy for a FTSE 100 company, but…

I have been in a B&M European Value Retail (BME) store a couple of times. It is alright or, as Malcolm smartly put it a few months ago, “cheap and cheerful, whilst still selling goods of a reasonable quality…just like Woolworth’s used to do”. I hope Malcolm purchased a few shares in the grocery and non-grocery business because the stock is up 20% or so since and also pays a 3% dividend yield (plus some special dividends). What do I think with the stock up 6% today to around a five quid share price (and a pleasingly akin circa £5 billion market cap)?

By Chris Bailey | Published 2023-05-31 09:40:12 |

B&M (#BME) – FY adj. EPS -12%, ordinary DPS -12%, expects higher adj. EBITDA this year

2023-05-31 06:35:59

B&M (#BME) – notes Q3 revenue growth and expects FY ahead of expectations, 20p per share special dividend

2023-01-05 07:25:55

The Wonder of Woolies Might Keep the Share Price Bubbling for this Cheery Retailer

Hello Share Collectors. This old punter won’t be the only one to remember with affection the old Woolworth’s stores. They were a treasure house in my fifties childhood and a great supplier of needs, both luxurious and essential. In my adulthood, I even have one of the pick n’ mix containers as a souvenir. Today’s choice for your further inspection is a bouncy high street retailer that seems to pursue a similar market.

By Malcolm Stacey | Published 2022-11-14 08:10:09 |

B&M (#BME) – H1 adj. EPS -23%, DPS maintained, reiterates previous guidance

2022-11-10 07:25:21

B&M (#BME) – Q1 constant currency revenue -2.2% YoY, though “improving trend” during quarter

2022-06-29 07:24:18

B&M (#BME) – FY adj. EPS -4.2%, DPS 16.5p, CFO Alex Russo to become CEO

2022-05-31 07:37:16

B&M (#BME) – CEO Simon Arora intends to retire in a year, company to commence succession process

2022-04-22 07:35:05

B&M (#BME) – Q3 adj. revenue +0.1%, UK LFL -6.2% though +14% on 2 year basis

2022-01-06 07:21:22

B&M (#BME) – H1 adj. EPS -7%, DPS +16%, “fully stocked”

2021-11-11 07:28:46

B&M (#BME) – Q1 constant currency revenue +3.1%, core UK LFL -4.4%

2021-07-08 07:23:48

B&M (#BME) – FY adj. EPS & DPS +114%, ahead many trading uncertainties

2021-06-03 07:25:01

B&M (#BME) – “strong” trading leads to increased FY adj. EBITDA expectations to £590m-£620m

2021-03-04 07:17:40

B&M (#BME) – 13 weeks to 26th Dec constant currency revenue +22.5%, 20p per share further special dividend

2021-01-07 07:23:17

B&M (#BME) – H1 revenue +25.3%, B&M UK fascia LFL +23%, DPS +59.2% & special dividend

2020-11-12 07:27:14

B&M (#BME) – “strong… revenue growth and profit uplift driven by elevated average spend per visit”

2020-09-29 07:17:59

Cheap and Cheerful B&M Is Worth a Look as it Makes Hay Despite the Virus

Hello Share Munchers. Some of us really miss the old Woolworths stores. And the nearest modern equivalent I can think of is B&M (BME). It seems the public also warm to B&M stores. They sell everything from food to household goods to, well, nearly everything that’s not too big. Now we all know that high street stores suffered during the epidemic. But not B&M it seems...

By Malcolm Stacey | Published 2020-09-14 08:10:00 |

B&M (#BME) – financial detail re. its previous “well placed to continue to grow profitably in the UK and continue to develop and prove the proposition in France”

2020-07-28 07:14:33

B&M (#BME) – FY PBT slightly higher, DPS increased to 8.1p, “trading since the year-end has been strong”

2020-06-11 07:36:21

B&M (#BME) – 8 week UK fascia LFL revenue +22.7%, excluding DIY & Gardening +10.3%

2020-05-29 07:16:22

previous 20 Page 2 of 3 (55 articles) next 15

Latest News

Show All

UPDATED: Lucian Miers & Jim Mellon are coming back to Sharestock in 2027: early bird tickets now on sale, event 15% sold out!

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

Evil Banksta weighs in on TekCapital after today’s spooftastic RNS

Good news travels fast but bad news….the case of Skinbiotherapeutics

Mothercare: the end is nigh, don’t blame Trump, I told y’all eons ago

EXPOSE: Nuburu shares in a slump post relisting on American Stock Exchange and latest accounts contain a material error

Letter to Pointon Young, former auditors to Amazing AI

Reinvesting my Satsuma Winnings

Tribal Group – “Proposed Acquisition by Main Capital Partners” provides us with another share tip winner

Quantum Data Energy - why are its shares still suspended?

Recent Comments

TOM18 Sep 2026

a shareholder could call a meeting to propose new directors by PM & pals own 50% of the equity sod vote it down

Letter to Pointon Young, former auditors to Amazing AI

AIMINVESTOR18 Sep 2026

This makes a mockery of the the so called rules and regulations when something as blatant as this is done.It's a shame a shareholder can't propose themselves as a director just to prevent the strike-off.Is there nothing legal that can be done at this point?

Letter to Pointon Young, former auditors to Amazing AI

TOYIN18 Sep 2026

Thanks Tom, just picked some more up sub 8p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

JOHN BROWN18 Sep 2026

It's outrageous that the likes of Amy Hunt claim that women with Sydney Sweeney's body shape cannot play sport. Who said that sportswomen can't look like Ms Sweeney?

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

MICKTHELINGE18 Sep 2026

If it gets to 3p then construction will be going well and it will be well on the way to 6p+ so interested in why you would sell out then?

Reinvesting my Satsuma Winnings

TOM18 Sep 2026

Whatever Opti's intentions it will have to sell.You could say you should sell now as maybe your last chance to sell at above 8oops too late, now 7.5p to sell

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

I thought that a seasoned reader of financial statements would have clocked that OPTI's HY results to 30/6/26 classed their SBTX shares as non-current assets – meaning that management has no intention to sell them within 12 months.Maybe you assumed that they were forced to class them as non-current because SBTX shares were suspended…but no, the SBTX suspension was lifted weeks before OPTI's sign-off date.And if you believe that OPTI haven't sold all or most of their remaining SBTX shares since June 30th, I'm afraid they saw you coming.There is of course a risk that OPTI has double accounted for its SBTX shares, having included them in both non-current assets and in "cash and equivalents", which might be a fruitful line of enquiry for you.As for Skin's RNS arriving a day outside the standard 10th-20th definition of mid-month, they have had a lot of balls to juggle so a 24hr delay ought to be a cause for congratulations.Why not grab some SBTX shares this afternoon? Could be your last chance to buy back below 12p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

Notwithstanding your ad nauseam negativity on SBTX, I choose to believe the positive indications from the 8 June RNS, including "Growth continued across the company", under Current Trading and Outlook (from a chairman who never speaks with forked tongue). Accordingly, I have helped myself to a nice top-up in anticipation of a welcome trading update on Monday.

Tom Winnifrith Bearcast: Hang on for the PS in the podcast

BOBINS18 Sep 2026

lets hope the Houthis keep away from the Saudi Mines?

Reinvesting my Satsuma Winnings

Charles18 Sep 2026

Easy work for the FCA with you having laid it out.

EXPOSE: Paul Mathieson and the strike off: you might think that, I could not comment